Introduction
The human immunoglobulin lambda light chain gene (IGL) has been mapped to chromosome 22q11. [1] [2] [3] The locus contains 36 V gene segments with an open reading frame (but only 31 of them have been found in functional rearrangements), 33 pseudo gene segments, and seven J-C gene regions. 3, 4 A genetic amplification polymorphism of the C2-C3 region can lead to the presence of up to 10 J-C gene regions per allele. 5 The V gene segments are grouped into 10 families, which are organized in three separate clusters. 6 Cluster A is located proximal to the J-C regions and contains families VII and III, cluster B contains family VI, one member of family IV, and families V, VII, and IX, whereas the remaining members of family VIV, as well as families VI, VIII and X are grouped in cluster C. 6 The gene regions J-C1, J-C2, J-C3, and J-C7 are functional, while J-C4, J-C5, and J-C6 are non-functional (pseudo) gene regions. 2, 7, 8 The J-C4 region has a deletion of approximately 1150 bp and in the 3′ end of the C5 exon 11 bp are deleted. 2 Moreover, the recombination signal sequences (RSS) of the J4 and J5 gene segments do not con- tain all essential nucleotides. 9 The C6 region contains a duplication of four nucleotides which results in a premature stop codon. 2 
Oz
− . 1 The serological isotype markers Mcg, Kern (Ke) and Oz are based on amino acid differences found in the C region of various Bence-Jones proteins from multiple myeloma (MM) patients and Ig chains isolated from intact immunoglobulins. 1, 11, 12 The four isotypes were initially assumed to be encoded by the four functional J-C gene regions J-C1, J-C2, J-C3, and J-C7, respectively. Since at least one third of all B cell malignancies have rearranged IGL genes, J-C region-specific Southern blot probes were developed to detect and identify clonal IGL rearrangements in these malignancies.
14 In this study, these 'isotype-specific' DNA probes were used to determine the frequency of J-C gene rearrangements in a large series of 212 B cell malignancies: 76 precursor-B acute lymphoblastic leukemias (precursor B-ALL), 74 Ig + chronic B cell leukemias (CBL), 34 Ig + B cell non-Hodgkin lymphomas (B-NHL), and 28 Ig + MM. The results of the J-C rearrangement patterns in the MM are compared with the reported frequencies of Ig isotype protein expression. We assume that the Ig isotype rearrangement patterns in the various types of B cell malignancies can give insight into Ig isotype usage and/or Ig isotype selection during B cell differentiation.
Materials and methods

Cell samples
For this study, 212 B cell malignancies were selected based on the availability of sufficient cells for DNA extraction, on their tumor load (ie Ͼ70% for leukemias and B-NHL and Ͼ25% for multiple myelomas) and on the membrane or cytoplasmic expression of Ig in case of mature Ig + malignancies. In this way 212 patient samples were selected, including the 40 patients who have previously been described: 14 
Southern blot analysis
DNA was isolated as previously described. 15 Fifteen micrograms of DNA were digested with the appropriate restriction enzymes (Pharmacia). The restriction fragments were size fractionated in 0.7% agarose gels and transferred by vacuum blotting to Nytran-13N nylon membranes (Schleicher and Schuell, Dassel, Germany). The membranes were hybridized with 32 P-random oligonucleotide labeled probes. 15 
DNA probes and IGL gene restriction map
In order to identify clonal IGL rearrangements in the J-C gene locus, seven isotype-specific DNA probes were used, which specifically recognize the seven J-C regions: the IGLC1D probe for the J-C1 region, the IGLJ2 probe for the highly homologous J-C2 and J-C3 regions, the IGLC2D probe, which exclusively recognizes the J-C2 gene region, and the IGLC4D, IGLJ5, IGLJ6 and the IGLJ7 probes for the last four J-C gene regions.
14 These probes were used in combination with HindIII, BglII, BamHI/HindIII, EcoRI/HindIII restriction enzyme digests. 14 The restriction map of the J-C gene region is given in Figure 1 . The 'general' C probe (IGLC3) was used in combination with EcoRI/HindIII digests and is also indicated in Figure 1 .
16
Results and discussion
Although about 40% of all B cell malignancies have rearranged IGL genes that can be employed for clonality studies, 17 IGL gene rearrangements are rarely studied in B cell malignancies because of the complex structure of the human IGL locus. This is the first detailed study on IGL isotype rearrangements in a large series of 212 B cell malignancies using a set of seven IGL isotype probes.
14 Combined use of these isotype-specific IGL probes together, theoretically detects all IGL gene rearrangements.
Figure 1
Structure and restriction map of the J-C region of the human IGL gene complex. 2, 8, 14 The location of the relevant HindIII (H), BglII (Bg), BamHI (B), and EcoRI (E) sites are indicated. The partially resistant HindIII and EcoRI restriction sites downstream of the C4 and C7 exons, respectively, are in parentheses. The solid boxes represent the functional C exons and the shaded boxes represent the non-functional pseudo C exons. The probes are indicated as solid bars. These probes are specific for the corresponding J-C gene segments, except for the IGLJ2 probe, which recognizes both the J-C2 and J-C3 gene regions (98% homology), and the general IGLC3 which recognizes all C exons (85% homology) of the classical IGL locus 15 and the C exons of the surrogate -like gene complexes 14.1, 16.1, 16.2, and 18.2. 16 The recognized region of the IGLJ2 probe in the J-C3 region is indicated with an open bar.
Frequency of IGL gene rearrangements
In all 136 Ig + B cell malignancies at least one IGL gene rearrangement was found by Southern blot analysis; in 35% (47/136) of cases both IGL alleles were rearranged and in one B-CLL even three IGL rearrangements were identified (Table 1) .
In contrast, in only 20% (15/76) of precursor B-ALL IGL rearrangements were found. This frequency is similar as described previously. 18 In 10 precursor B-ALL a single IGL gene rearrangement was found, in four cases biallelic IGL gene rearrangements, and one case even had three rearranged IGL alleles.
Precursor B-ALL arise from B cell precursor cells that are transformed at an immature differentiation stage in which the recombinase enzyme system is continuously active. 19 This results in the occurrence of ongoing Ig gene rearrangements in 30 to 40% of cases and cross-lineage T cell receptor gene rearrangements in approximately 90% of cases. [20] [21] [22] [23] Despite this continuous activity of the recombinase enzyme system, we observed only a low frequency of 20% IGL rearrangements. This might be caused by a lower accessibility of the IGL locus for recombination at this immature differentiation stage. 17 The frequency of IGL gene rearrangements in precursor B-ALL is higher than in Ig + CBL, which have IGL rearrangements in only 5% of cases. 24 CBL arise from B cells that are transformed after the Ig gene rearrangement process has been completed successfully, resulting in surface Ig expression. These malignancies show the expected Ig light chain gene rearrangement pattern, which can be described by the ordered model of Ig light chain rearrangements: start of recombination in the Ig kappa (IGK) locus, followed by IGK deletion and IGL gene rearrangements, and a stop of recombination as soon as a functional protein is expressed on the cell surface. [24] [25] [26] The low frequency of IGL gene rearrangements in Ig + CBL is probably caused by inaccessibility of the IGL locus and downregulation of the recombinase enzyme system as soon as a functional Ig protein is formed. The continuous recombinase activity in precursor B-ALL apparently partly overcomes the inaccessibility of the IGL locus, resulting in higher frequencies of the IGL gene rearrangements than found in mature Ig + B cell malignancies. 
J-C usage
Most rearrangements in our series of 212 B cell malignancies involved the J-C3 region (50%), followed by J-C2 (38%) and J-C1 (9%), while rearrangements to the J-C6 and J-C7 regions were rare (2% and 0.5%, respectively) ( Table 1 ). In one CBL and one B-NHL patient the IGL gene rearrangements could not be identified precisely, which might be caused by a chromosome aberration, for example t(18;22). Rearrangements to J-C4 and J-C5 were not found (Table 1) , which could be expected from the lack of several essential nucleotides in the heptamer sequences of the J4 and J5 RSS. 
Leukemia
Ig
+ B cell malignancies might be explained by the fact that the J-C6 region can only encode a truncated protein, which cannot contribute to a functional Ig molecule. 10 The percentages of J-C usage in our series of Ig + B cell malignancies are in agreement with the results of Ignatovich et al, 27 which are based on unbiased Ig cDNA libraries from PB of five healthy individuals (Table 2) . However, Farner et al 28 recently reported a much higher percentage of J7 usage (60% in productive rearrangements and 54% in non-productive rearrangements) by single-cell PCR on purified CD19
+ and CD5 − PB B-cells (Table 2 ). This unexpectedly high frequency of J7 usage in normal CD5
+ and CD5
− PB B-lymphocytes is in full contrast to the report of Ignatovich et al 27 (0.6%), to our results in B cell malignancies (0.5%) and to literature data on Ig isotype usage in MM patients (Ͻ1%). 1, 11, 12, 29 This discrepancy cannot easily be explained from an immunobiological point of view, but it might well be caused by a technical pitfall, such as inappropriate primer design.
The low frequency of rearrangements to the J-C6 and J-C7 gene regions might partly be attributed to the larger distance from the V gene segments as compared to the J-C1, J-C2 and J-C3 regions. However, proximity is probably not the only factor influencing the J-C usage, 30 as was demonstrated by the results in precursor B-ALL where 19% of the rearrangements did involve the J-C6 region.
In the surface Ig + B cell malignancies (CBL and B-NHL) rearrangements occurred most frequently to the J-C3 gene region (54%), followed by J-C2 (32%) and J-C1 (11%), while rearrangements in Ig + MM most frequently involved the J-C2 region (60%) (Figure 2b ), followed by J-C3 (37%) and J-C1 (3%). The two-fold increase of J-C2 rearrangements in MM coincided with a four-fold decrease of J-C1 rearrangements and a 1.5-fold decrease of J-C3 rearrangements (Table 2 ). This statistically significant shift (P Ͻ 0.0064) ( 2 test, with P Ͻ ␣, and ␣ = 0.05) from preferential J-C3 rearrangements in CBL and NHL to preferential J-C2 rearrangements in MM might be due to Ig isotype selection processes during terminal B cell differentiation.
When comparing J-C isotype usage in normal PB B cells (Ignatovitch et al) and SmIg
+ malignant B cells, there is a significant shift from J-C1 (27% vs 12%) to J-C3 (34% vs Therefore, it is unlikely that receptor editing induced by unfavorable somatic mutations is the sole explanation for the observed significant difference in J-C usage.
Correlation between IGL isotype gene rearrangements and Ig isotype protein expression in multiple myeloma
The distribution of Ig isotype gene rearrangements in MM resembles the reported Ig isotype pattern of Bence-Jones proteins. C2 (Ke (Table 3) . 12, 29 However, in the Bence-Jones protein studies, the frequency of C1 (Mcg) expression appeared to be higher (23%) than the frequency of J-C1 isotype gene rearrangements that we observed in our multiple myeloma series (3%) ( Table 3 ). It might be that the series of Bence-Jones proteins studied was a non-random selection or that in our random series C1 was underrepresented. Alternatively, it might be that the formation of Bence-Jones proteins is influenced by the isotype of the Ig chain.
The IGL-specific isotype probes used can not discriminate between rearrangements in normal J-C2 regions and polymorphic J-C2 regions. However, the reported combined frequency of Ke
−
Oz
− and Ke + Oz − Bence-Jones proteins (57%) is comparable to our frequency of J-C2 rearrangements (60%) 12 The number of Bence-Jones proteins studied in the study by Walker et al is corrected for duplicates with the study by Fett and Deutsch. c According to Niewold et al 13 the frequency of Mcp isotype is Ͻ1%. d The IGLJ2 and IGLC2D probes can not discriminate between rearrangements in normal and polymorphic J-C2 regions.
in MM (Table 2) , which would favor the assumption that Ke + Oz − proteins might be encoded by a polymorphic J-C2 region.
Strategies for probe/enzyme combinations in analysis of IGL gene rearrangements
Based on our data of IGL gene rearrangements in B cell malignancies, several strategies can be proposed for clonality studies. The Southern blot data indicate that 97% (197/204) of the rearrangements occurred to the J-C1, J-C2, and J-C3 region, while rearrangements to the remaining J-C regions were rare (2%, 5/204) with another two rearrangements (1%, 2/204) remaining unidentified.
In this study the seven isotype-specific probes were used in 15 probe-enzyme combinations. As a consequence of this extensive analysis all IGL gene rearrangements were detected and 99% of the rearranged IGL alleles were identified (Table  4) . However, we wanted to reduce the high number of hybridizations. For this purpose, it was determined to what extent the general C probe (IGLC3) detected all IGL rearrangements. In combination with EcoRI/HindIII digests this probe detected rearrangements in 97% of the 151 B cell malignancies with rearranged IGL genes and 94% of the rearranged IGL alleles (Table 4) . However, a disadvantage of this approach is the difficult interpretation of the complex banding pattern, with germline and rearranged bands of different density, which is caused by variable degrees of hybridization of the IGLC3 probe to C gene segments of the classical and surrogate IGL loci (Figure 3a) . 14, 16 Particularly in case of lower tumor loads (Ͻ75%) the detection of rearranged bands is less efficient due to faint signals. For example, rearrangements to the J-C1 region can easily be missed (eg, patient 1 If no identification is required, it is possible to restrict Southern blot analysis to a single hybridization with the IGLJ2 probe, because IGLC1D and IGLJ2 reside on the same BglII restriction fragment.
Figure 3
Comparative Southern blot analysis in B cell malignancies. Control DNA, and DNA from five Ig + malignancies were digested with EcoRI/HindIII or BglII, and hybridized with and 2 in Figure 3a, d) , because of reduced homology (93%) between the C1 gene sequence and the IGLC3 probe. 14 Since 97% of all IGL rearrangements occurred to the first three J-C regions, we evaluated the use of IGLC1D, IGLC2D, and IGLJ2 probes in combination with EcoRI/HindIII, BglII and HindIII digests (see Figure 1) . During the first round of hybridization the IGLC2D probe can be hybridized to EcoRI/HindIII filters and the IGLC1D probe to BglII and HindIII filters and in a second round hybridization the IGLJ2 probe can be applied to EcoRI/HindIII and BglII filters. These five Leukemia hybridizations resulted in identification and detection of 96% of all IGL gene rearrangements (Table 4 , Figure 3b, c, d ). With this combination, 99% of patients with an Ig + malignancy could be identified. Only in precursor B-ALL approximately 27% of the patients were missed (Table 4) , mainly because they had J-C6 rearrangements. In contrast to the IGLC3 probe, the IGLC1D probe easily identified all J-C1 rearrangements (Figure 3a, d) .
In case of limited amounts of DNA, one might decide to restrict the analyses to a single BglII digest and successive hybridization with the IGLJ2 probe and the IGLC1D probe. This approach allowed detection and identification of 93% (190/204) of all IGL gene rearrangements, and 94% (142/151) of the patients, but discrimination between J-C2 and J-C3 rearrangements was difficult if the tumor load was not high (Ͻ75%) and the four J-C6 rearrangements in precursor B-ALL were missed. Most clonality studies are needed for supporting the diagnosis of mature B cell malignancies (not for precursor B-ALL) and for such clonality studies it is generally not necessary to identify the IGL gene rearrangement as involving J-C1, J-C2, or J-C3. Therefore it is in principle possible to restrict the Southern blot analysis to application of the IGLJ2 probe in BglII digests, because this probe hybridizes to both the J2 and J3 regions and also detects rearrangements in the J1 region, since J-C1 and J-C2 are located on the same BglII restriction fragment (see Figure 1 ). According to our data, this single probe-enzyme approach results in detection of 95% (174/183) of all IGL gene rearrangements in Ig + B cell malignancies and clonality detection in 96% (131/136) of the patients (Table 4 ). The reason for missing some rearrangements was comigration of two rearranged bands or a rearranged and germline band, which is prevented by use of a second digest (HindIII). An important advantage of this approach is that the same BglII filter can be used for analysis of gene rearrangements in the IGH locus with the IGHJ6 probe and for rearrangements in the IGK locus with the IGKJ5 and IGKDE probes. 14, 15, 33, 34 This would imply that a single BglII digest in combination with four successive hybridizations (IGHJ6, IGKJ5, IGKDE and IGLJ2) would provide insight in the configuration of the IGH, IGK, and IGL genes. Generally we advise the use of two restriction enzyme digests per probe for reliable Southern blot analysis. 15, [33] [34] [35] Nevertheless, our data indicate that BglII digests are informative in the vast majority of cases (Ͼ95%) and rarely show restriction fragment length polymorphisms in the relevant IGH, IGK and IGL regions. 14, 15, 33, 34 
Conclusion
Our extensive data on IGL isotype specific gene rearrangements in a large series of 212 B cell malignancies show that in Ͼ96% of cases the J-C1, J-C2 or J-C3 gene region was involved, while rearrangements to J-C6 and J-C7 were rare and J-C4 and J-C5 recombinations were completely absent. Moreover, J-C6 rearrangements were exclusively found in precursor B-ALL. For efficient and reliable Southern blot analysis, we advise the use of a BglII digest in combination with the IGLJ2 probe, which allows detection of J-C1, J-C2, and J-C3 rearrangements, covering 95% of the rearrangements in Ig + B cell malignancies. Use of a second digest (HindIII) will exclude the chance of missing a rearranged allele due to comigration of rearranged and germline bands. For precursor B-ALL we recommend the inclusion the IGLJ6 probe in addition to the above-mentioned probes, because J-C6 recombinations represented 19% of the IGL gene rearrangements in precursor B-ALL.
